Ling Cai
Impact in
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 1%
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Genomics and Chromatin Dynamics
- Cancer-related gene regulation
- Protein Degradation and Inhibitors
- Histone Deacetylase Inhibitors Research
Papers in
-
- Protein Degradation and Inhibitors 18
- Epigenetics and DNA Methylation 16
- RNA modifications and cancer 15
- Genomics and Chromatin Dynamics 11
-
- Lung Cancer Treatments and Mutations 25
- Lung Cancer Diagnosis and Treatment 11
- Co-authors
- Benjamin P. Tu (9 shared papers)Gang Greg Wang (29 shared papers)Benjamin M. Sutter (1 shared paper)Bing Li (1 shared paper)Jin Chen (29 shared papers)Deyou Zheng (10 shared papers)Huijun Jiang (17 shared papers)Mark P. Kamps (1 shared paper)
- Journals
- Chinese Journal of Cancer (5 papers)Nature Communications (5 papers)Journal of Clinical Oncology (4 papers)Oncogene (4 papers)Blood (4 papers)
- Partner nations
- United StatesChinaSouth Korea
In The Last Decade
Ling Cai
187 papers receiving 8.3k citations
Ling Cai's Hit Papers
Peers
Comparison fields: 5 of 161
- Cancer Research 1.6k
- Molecular Biology 4.9k
- Pulmonary and Respiratory Medicine 1.6k
- Oncology 1.2k
- Hematology 443
Countries citing papers authored by Ling Cai
This map shows the geographic impact of Ling Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Cai more than expected).
Fields of papers citing papers by Ling Cai
This network shows the impact of papers produced by Ling Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Cai. The network helps show where Ling Cai may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling Cai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 194 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade Hit paper breakdown → | 2013 | 703 |
| 2 | Acetyl-CoA Induces Cell Growth and Proliferation by Promoting the Acetylation of Histones at Growth Genes Hit paper breakdown → | 2011 | 547 |
| 3 | Acetate Dependence of Tumors Hit paper breakdown → | 2014 | 539 |
| 4 | 2007 | 447 | |
| 5 | 2007 | 323 | |
| 6 | Phase separation drives aberrant chromatin looping and cancer development Hit paper breakdown → | 2021 | 294 |
| 7 | 2019 | 278 | |
| 8 | 2005 | 251 | |
| 9 | 2011 | 217 | |
| 10 | 2012 | 181 | |
| 11 | 2014 | 173 | |
| 12 | 2012 | 168 | |
| 13 | 2021 | 133 | |
| 14 | 2018 | 123 | |
| 15 | 2018 | 122 | |
| 16 | 2022 | 119 | |
| 17 | 2011 | 111 | |
| 18 | 2022 | 107 | |
| 19 | 2018 | 93 | |
| 20 | 2021 | 91 |
About Ling Cai
Ling Cai is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 194 papers that have together received 8.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (25 papers), Protein Degradation and Inhibitors (18 papers), Epigenetics and DNA Methylation (16 papers), RNA modifications and cancer (15 papers), Lung Cancer Research Studies (13 papers), Cancer Genomics and Diagnostics (13 papers), Genomics and Chromatin Dynamics (11 papers) and Lung Cancer Diagnosis and Treatment (11 papers). The work is most often cited by research in Cancer Research (1.6k citations), Molecular Biology (4.9k citations), Pulmonary and Respiratory Medicine (1.6k citations), Oncology (1.2k citations) and Hematology (443 citations). Ling Cai has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Benjamin P. Tu, Gang Greg Wang, Benjamin M. Sutter, Bing Li, Jin Chen, Deyou Zheng, Huijun Jiang, Mark P. Kamps, Martina P. Pasillas and Charles L. Sawyers. Their work appears in journals such as Chinese Journal of Cancer, Nature Communications, Journal of Clinical Oncology, Oncogene and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.